Login / Signup

Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients.

Arunothai RakmanothamChatphatai MoonlaDarintr Sosothikul
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
gov NCT05281185.
Keyphrases
  • low dose
  • end stage renal disease
  • high dose
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis